menu search

Merck kgaa predicts more earnings gains on lab supplies demand

Germany's Merck KGaA said it expected strong earnings growth this year, driven by its Life Science unit, which supplies materials and gear to COVID-19...

March 3, 2022, 1:25 am

Merck kgaa predicts more earnings gains on lab supplies demand

Germany's Merck KGaA said it expected strong earnings growth this year, driven by its Life Science unit, which supplies materials and gear to COVID-19...

March 3, 2022, 1:25 am

Merck kgaa predicts more earnings gains on lab supplies demand

Germany's Merck KGaA said it expected strong earnings growth this year, driven by its Life Science unit, which supplies materials and gear to COVID-19...

March 3, 2022, 1:25 am

Lianbio: an undervalued play on the $220b/year chinese pharmaceutical market

LianBio: An Undervalued Play On The $220B/Year Chinese pharmaceutical Market...

March 2, 2022, 11:41 pm

Lianbio: an undervalued play on the $220b/year chinese pharmaceutical market

LianBio: An Undervalued Play On The $220B/Year Chinese pharmaceutical Market...

March 2, 2022, 11:41 pm

Lianbio: an undervalued play on the $220b/year chinese pharmaceutical market

LianBio: An Undervalued Play On The $220B/Year Chinese pharmaceutical Market...

March 2, 2022, 11:41 pm

Kuehne + nagel 2021 earnings swell on 50% air, ocean margins

Kuehne + Nagel, the world's largest air and sea freight forwarder by volume, was richly rewarded last year by supply chain disruptions, elevated rates...

March 2, 2022, 11:22 pm

Kuehne + nagel 2021 earnings swell on 50% air, ocean margins

Kuehne + Nagel, the world's largest air and sea freight forwarder by volume, was richly rewarded last year by supply chain disruptions, elevated rates...

March 2, 2022, 11:22 pm

Kuehne + nagel 2021 earnings swell on 50% air, ocean margins

Kuehne + Nagel, the world's largest air and sea freight forwarder by volume, was richly rewarded last year by supply chain disruptions, elevated rates...

March 2, 2022, 11:22 pm

Fate therapeutics to present at upcoming march investor conferences

SAN DIEGO, March 02, 2022 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage ...

March 2, 2022, 4:01 pm

Fate therapeutics to present at upcoming march investor conferences

SAN DIEGO, March 02, 2022 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage ...

March 2, 2022, 4:01 pm

Fate therapeutics to present at upcoming march investor conferences

SAN DIEGO, March 02, 2022 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage ...

March 2, 2022, 4:01 pm

Why jazz pharmaceuticals stock is racing higher today

The biotech's better-than-expected Q4 financial results are fueling a rally in its stock....

March 2, 2022, 2:20 pm

Why jazz pharmaceuticals stock is racing higher today

The biotech's better-than-expected Q4 financial results are fueling a rally in its stock....

March 2, 2022, 2:20 pm

Why jazz pharmaceuticals stock is racing higher today

The biotech's better-than-expected Q4 financial results are fueling a rally in its stock....

March 2, 2022, 2:20 pm

Amneal pharmaceuticals (amrx) ceo, chirag patel on q4 2021 results - earnings call transcript

Amneal pharmaceuticals (AMRX) CEO, Chirag Patel on Q4 2021 Results - Earnings Call Transcript...

March 2, 2022, 1:13 pm

Amneal pharmaceuticals (amrx) ceo, chirag patel on q4 2021 results - earnings call transcript

Amneal pharmaceuticals (AMRX) CEO, Chirag Patel on Q4 2021 Results - Earnings Call Transcript...

March 2, 2022, 1:13 pm

Amneal pharmaceuticals (amrx) ceo, chirag patel on q4 2021 results - earnings call transcript

Amneal pharmaceuticals (AMRX) CEO, Chirag Patel on Q4 2021 Results - Earnings Call Transcript...

March 2, 2022, 1:13 pm

Canaccord genuity calls zynerba "undervalued," reiterates buy rating after positive 4q results

Canaccord Genuity (TSX:CF, LSE:CF) said it continued to believe that Zynerba pharmaceuticals (NASDAQ:ZY...

March 2, 2022, 11:59 am

Canaccord genuity calls zynerba "undervalued," reiterates buy rating after positive 4q results

Canaccord Genuity (TSX:CF, LSE:CF) said it continued to believe that Zynerba pharmaceuticals (NASDAQ:ZY...

March 2, 2022, 11:59 am


Search within

Pages Search Results: